Provenance du réseau au premier degré de Pierre Dechelotte
Entité | Type d'entité | Industrie | |
---|---|---|---|
TargEDys SA
TargEDys SA BiotechnologyHealth Technology TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France.
9
| Subsidiary | Biotechnology | 9 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Pierre Dechelotte via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | Corporate Officer/Principal | |
NATUREX | Food: Specialty/Candy | Director/Board Member | |
Laboratoires Fournier SAS
Laboratoires Fournier SAS Pharmaceuticals: MajorHealth Technology Laboratoires Fournier SAS manufactures pharmaceutical preparations. The company was founded on July 10, 2007 and is headquartered in Rungis, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Fidia Farmaceutici SpA
Fidia Farmaceutici SpA Medical SpecialtiesHealth Technology Fidia Farmaceutici SpA manufactures pharmaceutical products. The firm's platform technology level is the chemical modification, development, and manufacturing of state-of-the-art pharmaceuticals and medical devices based on hyaluronan covering therapeutic categories. The company was founded in 1946 and is headquartered in Abano Terme, Italy. | Medical Specialties | Corporate Officer/Principal | |
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investment Managers | Private Equity Investor Chief Executive Officer Investment Committee Member | |
CM&D Pharma Ltd.
CM&D Pharma Ltd. Pharmaceuticals: MajorHealth Technology CM&D Pharma Ltd. provides pharmaceutical products. It is a specialty pharmacy company focused on foods for special medical purposes. Its products include Fostrap CKD, Recoclix, SilSOS, Eviendep, and Ossulin. The company was founded in 2007 and is headquartered in Surrey, UK. | Pharmaceuticals: Major | Founder | |
University of Padua | College/University | Doctorate Degree | |
Nemysis Ltd.
Nemysis Ltd. BiotechnologyHealth Technology Nemysis Ltd. provides IP platform for medical treatments. It engages in the development of portfolio of IP protected, science-based compounds and products. The company was founded on October 21, 2005 and is headquartered in Dublin, Ireland. | Biotechnology | Chief Executive Officer | |
ExPharma Ltd.
ExPharma Ltd. BiotechnologyHealth Technology ExPharma Ltd. is a virtual healthcare company. It specializes in food supplements, foods for special medical purposes, medical devices, and diagnostics. The company was founded on September 4, 2012 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman | |
Prismic Pharmaceuticals, Inc.
Prismic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prismic Pharmaceuticals, Inc. engages in the research and development of prescription drugs for kidney disease, mental health, and chronic pain. It also offers medical foods for patients with chronic kidney disease, and depression and bipolar disorder. The company was founded by Zachary Dutton, Danilo Casadei Massari, and Peter J. Moriarty in 2011 and is headquartered in Worcester, MA. | Pharmaceuticals: Major | Founder | |
Ajinomoto Cambrooke, Inc.
Ajinomoto Cambrooke, Inc. Pharmaceuticals: OtherHealth Technology Ajinomoto Cambrooke, Inc. operates as a therapeutic nutrition company. It offers Glytactin with GMP to help meet the nutritional needs of patients with Phenylketonuria; Tylactin with GMP to help meet the nutritional needs of patients with Tyrosinemia; amino acid formulas for the dietary management of disorders of amino acid metabolism; low protein food; KetoVie, ketogenic formulas for the dietary management of intractable epilepsy; and KetoVie Café Food low-carbohydrate ketogenic food for individuals following the spectrum of ketogenic diets. The company was founded by David Paolella and Lynn Paolella in 2000 and is headquartered in Ayer, MA. | Pharmaceuticals: Other | Director/Board Member | |
Actus Finance & Communication SAS
Actus Finance & Communication SAS Miscellaneous Commercial ServicesCommercial Services Actus Finance & Communication SAS is a French company that provides consulting and communication services. The private company is based in Paris, France. Philippe Lavielle has been the CEO of the company since 2016. Actus Finance & Communication was acquired by Actus Finance & Communication SA /Management/ from News Invest on May 07, 2014. | Miscellaneous Commercial Services | Chief Executive Officer | |
FERMENTALG | Food: Specialty/Candy | Chairman | |
École des Hautes Études Commerciales de Paris | College/University | Graduate Degree | |
Nextsens, Inc. | Chairman | ||
Genencor International BV (Belgium)
Genencor International BV (Belgium) Chemicals: SpecialtyProcess Industries Genencor International BVBA manufactures chemistry and inorganic raw materials and derivatives. IOt operates as a subsidiary company of Danisco A/S. The company was founded in 1995 and is located in Brugge, Belgium | Chemicals: Specialty | Corporate Officer/Principal | |
DuPont Cellulosic Ethanol LLC
DuPont Cellulosic Ethanol LLC Chemicals: SpecialtyProcess Industries Part of International Flavors & Fragrances, Inc., DuPont Cellulosic Ethanol LLC is a company that manufactures and supplies cellulosic ethanol. The company is based in Itasca, IL. The company was founded by Philippe Lavielle. | Chemicals: Specialty | Founder | |
Coldway SA
Coldway SA Wholesale DistributorsDistribution Services Coldway SA manufactures and sells sanitary storage solutions to the healthcare, logistics, and food industries. Its products include stand-alone refrigerated container, refrigerated roll, and other related equipment such as ice and insulated boxes. The company was founded by Laurent Rigaud and Francis Kindbeiter in 2001 and is headquartered in Pia, France. | Wholesale Distributors | Director/Board Member | |
Université de Rouen Normandie | College/University | Undergraduate Degree | |
THERANEXUS | Pharmaceuticals: Major | Director/Board Member | |
A-Mansia Biotech SA (Belgium)
A-Mansia Biotech SA (Belgium) Miscellaneous Commercial ServicesCommercial Services A-Mansia Biotech provides business services. The company was founded on October 11, 2016 and is headquartered in Ottignies-Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Pfizer, Inc. /Angers & Val-de-Reuil Pharmaceutical Operations | Pharmaceuticals: Major | Corporate Officer/Principal | |
Citryll BV
Citryll BV Miscellaneous Commercial ServicesCommercial Services Citryll BV is a private pharmaceutical company located in Oss, the Netherlands, at the Pivot Park. Citryll is dedicated to developing and commercializing therapeutics that target netosis and NETs, with a focus on immune-mediated inflammatory diseases. The Dutch company's lead antibody, Cit-013, has a unique dual mode of action and proprietary NET biomarker assays, making it a promising drug for rheumatoid arthritis and hidradenitis suppurativa. The initial clinical trials with Cit-013 are expected to provide the foundation for a new treatment paradigm for immune-mediated inflammatory diseases. The company was founded in 2015 by Helmuth van Es, Renato Chirivi, and the late Jos Raats of ModiQuest. | Miscellaneous Commercial Services | Director/Board Member | |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
University of Basel | College/University | Doctorate Degree | |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Investment Managers | Consultant / Advisor | |
Vivostat A/S
Vivostat A/S Medical SpecialtiesHealth Technology Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark. | Medical Specialties | Director/Board Member | |
École Centrale Paris | College/University | Undergraduate Degree | |
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
BIOPHYTIS S.A. | Pharmaceuticals: Other | Director/Board Member | |
MAAT PHARMA | Pharmaceuticals: Major | Director/Board Member | |
YSOPIA Biosciences SA
YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Biotechnology | Director/Board Member | |
Polaris SA /FR/
Polaris SA /FR/ Pharmaceuticals: MajorHealth Technology Polaris SA engages in the biotechnology industry and specializes in the field of healthy omega 3 lipids. The company was founded by St?phane Lozachmeur and Gildas Breton on July 1, 1994 and is headquartered in Quimper, France. | Pharmaceuticals: Major | Director/Board Member | |
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Financial Conglomerates | Director/Board Member |
Statistiques
Internationale
France | 21 |
Etats-Unis | 8 |
Royaume-Uni | 4 |
Italie | 3 |
Suisse | 3 |
Sectorielle
Health Technology | 23 |
Finance | 6 |
Consumer Services | 6 |
Commercial Services | 5 |
Process Industries | 4 |
Opérationnelle
Director/Board Member | 32 |
Corporate Officer/Principal | 13 |
Chairman | 10 |
Chief Executive Officer | 6 |
Founder | 5 |
Relations les plus connectées
- Bourse
- Insiders
- Pierre Dechelotte
- Connexions Sociétés